Embecta (EMBC) Cash from Investing Activities (2020 - 2026)
Embecta (EMBC) reported Cash from Investing Activities of -$500000.0 for Q1 2026, down 400.0% on a YoY basis from $166666.7 in Q1 2025, and down 105.26% sequentially from $9.5 million in Q4 2025.
Embecta (EMBC) Cash from Investing Activities (2020 - 2026) Analysis & Trends
Embecta (EMBC) has 7 years of Cash from Investing Activities data on file, last reported at -$500000.0 in Q1 2026.
- For the quarter ending Q1 2026, Cash from Investing Activities fell 400.0% year-over-year to -$500000.0; the trailing twelve-month figure through Mar 2026 stood at $1.3 million (up 111.5% YoY), and the FY2025 full-year result was -$9.3 million, up 41.14% from the prior year.
- Cash from Investing Activities retreated to -$500000.0 in Q1 2026, from $9.5 million in the prior quarter.
- In the past five years, Cash from Investing Activities ranged from a high of $9.5 million in Q4 2025 to a low of -$9.7 million in Q2 2024.
- A 5-year average of -$3.9 million and a median of -$5.0 million in 2022 frame the typical range for Cash from Investing Activities.
- Across the five-year window, Cash from Investing Activities jumped 733.33% in 2025 and plunged 400.0% in 2026, its largest moves.
- Tracing EMBC's Cash from Investing Activities over 5 years: stood at -$4.7 million in 2022, then jumped by 42.55% to -$2.7 million in 2023, then surged by 44.44% to -$1.5 million in 2024, then jumped by 733.33% to $9.5 million in 2025, then sank by 105.26% to -$500000.0 in 2026.
- Business Quant data shows EMBC's Cash from Investing Activities at -$500000.0 in Q1 2026, $9.5 million in Q4 2025, and -$7.3 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 125.80 Bn | 120.59 Bn | 1.96 Bn | -26.60 Mn |
| 2 | Becton Dickinson | 44.67 Bn | 43.85 Bn | 2.15 Bn | -139.00 Mn |
| 3 | Alcon | 33.10 Bn | 31.44 Bn | 1.53 Bn | -218.00 Mn |
| 4 | Medline | 32.86 Bn | 30.63 Bn | 1.84 Bn | -96.00 Mn |
| 5 | Resmed | 29.32 Bn | 27.66 Bn | 890.98 Mn | -58.03 Mn |
| 6 | West Pharmaceutical Services | 23.66 Bn | 23.22 Bn | 329.20 Mn | -43.20 Mn |
| 7 | Solventum | 14.00 Bn | 13.44 Bn | 1.10 Bn | -77.00 Mn |
| 8 | Cooper Companies | 13.88 Bn | 13.74 Bn | 735.40 Mn | -90.00 Mn |
| 9 | Align Technology | 12.04 Bn | 10.98 Bn | 736.59 Mn | -131.58 Mn |
| 10 | Embecta | 203.69 Mn | 10.29 Mn | 127.80 Mn | -500,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -500,000.00 |
| Mar 31, 2026 | -500,000.00 |
| Dec 31, 2025 | 9.50 Mn |
| Dec 31, 2025 | 9.50 Mn |
| Sep 30, 2025 | -7.30 Mn |
| Sep 30, 2025 | -7.30 Mn |
| Jun 30, 2025 | -400,000.00 |
| Jun 30, 2025 | -400,000.00 |
| Mar 31, 2025 | -100,000.00 |
| Mar 31, 2025 | -100,000.00 |
| Dec 31, 2024 | -1.50 Mn |
| Dec 31, 2024 | -1.50 Mn |
| Jun 30, 2024 | -9.70 Mn |
| Jun 30, 2024 | -9.70 Mn |
| Mar 31, 2024 | -3.40 Mn |
| Mar 31, 2024 | -3.40 Mn |
| Dec 31, 2023 | -2.70 Mn |
| Dec 31, 2023 | -2.70 Mn |
| Sep 30, 2023 | -9.20 Mn |
| Sep 30, 2023 | -9.20 Mn |